BFA
KYTH

BlackRock Fund Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

BlackRock Fund Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-965,015
Closed -$72.4M – 4405
2015
Q3 		$72.4M Sell
965,015
-225,038
-19% -$16.8M 0.02% 1166
2015
Q2 		$89.6M Buy
1,190,053
+93,595
+9% +$5.01M 0.02% 1089
2015
Q1 		$55M Buy
1,096,458
+106,138
+11% +$4.45M 0.01% 1446
2014
Q4 		$34.3M Buy
990,320
+109,424
+12% +$3.82M 0.01% 1730
2014
Q3 		$28.9M Buy
880,896
+26,832
+3% +$945K 0.01% 1734
2014
Q2 		$32.8M Buy
854,064
+148,924
+21% +$5.2M 0.01% 1689
2014
Q1 		$28M Buy
705,140
+139,969
+25% +$6.26M 0.01% 1811
2013
Q4 		$21.1M Buy
565,171
+277,987
+97% +$11.5M 0.01% 1968
2013
Q3 		$13.1M Buy
287,184
+33,305
+13% +$996K ﹤0.01% 2202
2013
Q2 		$6.87M Buy
+253,879
New +$5.81M ﹤0.01% 2491

BlackRock Fund Advisors's KYTH Position: Q4 2015 in Review

BlackRock Fund Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 965,015 shares — an estimated $72.4M sold.

BlackRock Fund Advisors first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $89.6M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • BlackRock Fund Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • BlackRock Fund Advisors sold 965,015 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $72.4M.
  • BlackRock Fund Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • BlackRock Fund Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $89.6M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on BlackRock Fund Advisors's 13F filing for Q4 2015, filed 11 Feb 2016.